The Giants of Cancer Care recognition program celebrates the achievements of leading physicians and researchers who have devoted their time, talent and resources to improving the care for the many patients and their families affected by cancer.
Past News ReleasesRSS
CHICAGO (PRWEB) June 03, 2016
OncLive®, a leading provider of news, resources and information to oncology professionals, today announced that an elite panel of oncology specialists has chosen finalists for the 2016 Giants of Cancer Care® Awards, which recognize and celebrate pioneers, innovators and future generations of leaders for their remarkable achievements in oncology research and clinical practice.
Now in its fourth year, the Giants of Cancer Care recognition program celebrates the achievements of leading physicians and researchers who have devoted their time, talent and resources to improving the care for the many patients and their families affected by cancer. Their discoveries have propelled the field forward and established the building blocks for future advances. Recipients demonstrate the qualities that distinguish this award from others: unlimited selflessness, compassion for their patients, and a desire to understand and develop life-changing treatments against a disease that affects so many.
Nominated by the oncology community, a total of 46 finalists were named in 10 categories, including breast cancer, gastrointestinal cancer, genitourinary cancer, hematologic cancer, lung cancer, melanoma, radiation oncology, scientific advances, surgical oncology, and community outreach. This year’s winners will be chosen by an exclusive selection committee of eminent oncologists, educators, clinicians and researchers, who will consider each finalist’s body of work, including clinical impact, significant contributions, and overall accomplishments.
The entire program is overseen by the Giants of Cancer Care advisory board, which is comprised of chairman Dr. Maurie Markman from Cancer Treatment Centers of America; Dr. Patrick Borgen from Maimonides Hospital; Dr. George D. Demetri from Dana-Farber Cancer Institute/Harvard Cancer Center; Dr. Hope S. Rugo from University of California, San Francisco/Helen Diller Family Comprehensive Cancer Center; and Dr. Heather Wakelee from Stanford University Medical Center.
“Unlike many other recognition programs, the Giants of Cancer Care honors oncology specialists who are nominated by their peers,” said Dr. Markman. “Previous winners include a diverse, esteemed group of groundbreaking individuals united by their passion to transform cancer from a deadly disease into a story of hope, survivorship and ultimately, a cure.”
Michael Hennessy Jr., president of Michael J. Hennessy Associates Inc., which produces OncLive, added, “The Giants of Cancer Care acknowledges the tireless efforts of physicians and researchers who improve patient care, develop groundbreaking treatments, and prolong the lives of those with cancer. In recognizing and honoring individuals who have achieved landmark success within the field of oncology, this dynamic program celebrates the oncology trailblazers of today while inspiring the next generation of potential Giants of Cancer Care award winners.”
The winners will be announced at the 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® from November 9-11 at the New York Marriott Marquis.
A digital platform of resources for practicing oncologists, OncLive.com offers oncology professionals information they can utilize to help provide the best patient care. OncLive is the official website for Michael J. Hennessy Associates Inc.’s Oncology Specialty Group, which publishes OncologyLive, Oncology Nursing News, Oncology Business Management and more. Michael J. Hennessy Associates Inc. is a full-service health care communications company offering education, research, medical media, curetoday.com and CURE® magazine, the largest U.S. consumer publication focused entirely on cancer. Combining science and humanity to make cancer understandable, CURE reaches patients, cancer centers and advocacy groups.
# # #